On 6 December 2021 the Anti-Doping Disciplinary Panel of India (ADDPI) decided in absentia to impose an 8 year period of ineligibility on the Athlete Gurmeet Singh for his second anti-doping rule violation after he tested positive for the prohibited substances Aandrosterone, Etiocholanolone, Testosterone and Adiols.
Hereafter the Athlete appealed the Decision with the Anti-Doping Appeal Panel of India (ADAPI). The Athlete denied the intentional use of the substances and could not explain of these substances had entered his system. He assumed that the supplements he used were the contaminated while he was willing to have his supplements tested.
INADA contended that this is the Athlete's second violation and in first instance failed to demonstrate that the violation was not intentional. Although duly informed the Athlete failed to join the proceedings, nor the hearing, nor filed any statement in his defence.
Further INADA asserted that without corroborating evidence the Athlete only alleged that his supplements were contaminated whereas the supplements mentioned on the Doping Control Form were not the source of the positive test.
The Appeal Panel confirms that the presence of prohibited substances had been established in the Athlete's sample and accordingly that he committed an anti-doping rule violation. The Appeal Panel deems that the Athlete failed to establish that the violation was not intentional, nor grounds for a reduced sanction.
Therefore ADAPI decides on 5 April 2022 to dismiss the Athlete's appeal and to uphold the ADDPI Decision of 6 December 2021 for the imposition of an 8 year period of ineligibility on the Athlete for his second anti-doping rule violation.
